Oppenheimer Reiterates Nurix (NRIX) at Outperform, 'see significant upside potential for NRIX'

June 29, 2026 8:20 AM

Oppenheimer analyst Kostas Biliouris reiterated an Outperform rating and $28.00 price target on Nurix (NASDAQ: NRIX).The analyst commented: "We like ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found